help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tetradis, S.
Right arrow Articles by Tsingotjidou, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tetradis, S.
Right arrow Articles by Tsingotjidou, A.
Endocrinology Vol. 142, No. 2 663-670
Copyright © 2001 by The Endocrine Society

ARTICLES

Parathyroid Hormone Induces Expression of the Nuclear Orphan Receptor Nurr1 in Bone Cells1

Sotirios Tetradis, Olga Bezouglaia and Anastasia Tsingotjidou

Division of Diagnostic and Surgical Sciences, UCLA School of Dentistry, Los Angeles, California 90095-1668

Address all correspondence and requests for reprints to: Sotirios Tetradis, Division of Diagnostic and Surgical Sciences, Room 53-068 CHS, UCLA, School of Dentistry, Los Angeles, California 90095-1668. E-mail: sotirist{at}dent.ucla.edu


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Following PTH treatment, immediate changes in osteoblast gene expression involve induction of primary response genes. Primary gene products subsequently mediate the osteoblast response to PTH. Using representational difference analysis (RDA) to isolate primary genes induced by PTH in osteoblasts, we identified Nurr1, a member of the NGFI-B nuclear orphan receptor subfamily. Nurr1 binds DNA as a monomer but also heterodimerizes with the 9-cis retinoic acid receptor (RXR). Nurr1’s importance in retinoic acid, vitamin D, and thyroid hormone signaling has been hypothesized. Nurr1 messenger RNA (mRNA) levels were maximal at 1 h and at 10 nM of PTH in primary mouse osteoblasts (MOB). Activation of the PKA and PKC pathways by 10 µM forskolin and 1 µM PMA, respectively, induced Nurr1 mRNA levels. However, inhibition of the PKA but not the PKC pathway significantly inhibited the PTH induction of Nurr1. Moreover, PTH(3–34) at 1–100 nM did not induce Nurr1 mRNA levels. Thus, PTH induction of Nurr1 in primary mouse osteoblasts is mediated primarily through the cAMP/PKA pathway. PTH also stimulated Nurr1 protein in MOB cells and Nurr1 mRNA in calvarial organ cultures. Nurr1 induction represents a potential cross-talk mechanism between PTH and steroid hormone signaling at the transcription factor level.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
PTH HAS significant effects on bone metabolism, being both anabolic and catabolic, depending on the pattern of exposure (1, 2, 3, 4). PTH signaling starts with PTH binding to the highly conserved PTH/PTH-related peptide (PTHrP) receptor at the cell surface of osteoblasts (5, 6). The PTH/PTHrP receptor belongs to the seven-transmembrane domain family of receptors that signal through activated G proteins (5). Upon PTH binding to its receptor and activation of G proteins, a signal transduction cascade is initiated that ultimately leads to changes in osteoblastic function. Three members of the G protein family are coupled to the PTH/PTHrP receptor and are of particular importance in PTH-induced gene expression. Gs and Gi activate and inhibit adenylate cyclase activity, respectively, and regulate the cAMP/protein kinase A (PKA) pathway (7, 8, 9, 10). Gq stimulates phospholipase C, resulting in diacylglycerol (DAG) and inositol triphosphate (IP3) production. DAG and IP3 then activate the protein kinase C (PKC) pathway and increase intracellular calcium (11, 12, 13).

Signaling through the PKA, PKC, and calcium pathways leads to phosphorylation and activation of various transcription factors, which in turn induce transcription of several osteoblastic genes (14). These genes are the first to be affected by PTH treatment and thus they are classified as primary response genes. Their induction is rapid, transient, and does not require new protein synthesis. Osteoblastic primary response genes induced by PTH include the transcription factors c-fos, c-jun and inducible cAMP early repressor (15, 16, 17, 18), the cytokine interleukin-6 (19, 20), the growth factor leukemia inhibitory factor (20), the signaling molecule regulator of G proteins signaling (RGS2, 21) and the enzymes prostaglandin G/H synthase-2 (22, 23) and tissue plasminogen activator (24). The products of primary response genes, in turn, regulate the expression of late PTH-target genes such as COL1A1 and collagenase (25, 26, 27), mediate the restoration of primary gene transcription to control levels (23), and have been implicated in the anabolic and catabolic effects of PTH on bone (28). To understand the mechanisms controlling PTH-mediated regulation of bone metabolism, it is imperative to identify PTH-induced primary response genes and characterize the molecular signals that mediate their induction.

To isolate PTH-induced primary response genes in osteoblasts, we performed representational difference analysis (RDA) using MC3T3-E1 preosteoblastic cells treated with PTH in the presence of the protein synthesis inhibitor cycloheximide (CHX). One of the clones that we identified was the nuclear orphan receptor Nurr1.

Nurr1 was originally isolated in neonatal mouse brain (29) while the rat and human homologs were induced during liver regeneration (30) and activation of T cells (31). Nurr1 can bind promoter elements as a monomer and activate transcription in the absence of ligand binding (30). Nurr1 can also form a transcriptionally active heterodimer with the 9-cis retinoic acid receptor (RXR, 32, 33). Interestingly, RXR heterodimerizes with the retinoic acid receptor (RAR), the thyroid hormone receptor (T3R) and with the vitamin D receptor to bind DNA (34). In fact, the importance of Nurr1 in retinoic acid, vitamin D, and thyroid hormone signaling has been hypothesized (33).

Since its initial discovery, Nurr1 has been described in various areas of the developing and adult brain (35, 36, 37, 38) and is induced in the brain by various stimuli, including focal brain injury (39), global ischemia (40), phencyclidine treatment (41), and permanent middle cerebral artery occlusion (42). Nurr1’s importance for brain function is supported by the observation that Nurr1 knock-out mice fail to generate midbrain dopaminergic neurons, are hypoactive and die soon after birth, possibly due to an inability to suckle (43). In addition to the brain, Nurr1 is induced in neuroblastoma cells by forskolin and phorbol esters (TPA, 44), in the adrenal gland by pentylene tetrazole (45), in leukemic cells after mechanical agitation (46), and in MCF-7 breast cancer cells by all-trans and 9-cis retinoic acids (47).

In the present study, we report that PTH rapidly induced Nurr1 mRNA levels in MC3T3-E1 cells, in osteoblastic cells from neonatal mouse calvariae, and in mouse calvariae organ cultures. PTH induction of Nurr1 gene expression was mediated primarily through activation of the cAMP-PKA signaling pathway. PTH also induced Nurr1 protein levels in osteoblastic cells. Thus, Nurr1 induction may represent a very interesting cross-talk mechanism between PTH and steroid hormone signal-transduction in regulating bone metabolism.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Reagents
All reagents were purchased from Sigma (St Louis, MO) unless otherwise specified. The bovine PTH(1–34) fragment was used for all the experiments except the PTH analog experiment (see Fig. 8Go) where the amide bovine PTH(1–34) and (3–34) fragments were used.



View larger version (51K):
[in this window]
[in a new window]
  		Figure 8. Effects of PTH analogs on the induction of Nurr1 mRNA levels. MOB cells were treated for 1 h with 10 nM PTH(1–34) or 1 to 100 nM PTH(3–34). Northern blot analysis of Nurr1 and GAPDH mRNA levels and ethidium bromide staining of RNA are shown.

 
Cell and organ culture
MC3T3-E1 cells were plated at 5000 cells/cm2 and grown to confluence for 8 days in DMEM supplemented with 10% FBS, 100 U/ml penicillin, and 50 µg/ml streptomycin in a humidified atmosphere of 5% CO2 at 37 C. Media were changed every 3 days.

All animals used in our studies were killed according to protocol approved by UCLA Institutional Animal Care and Use Committee (ARC No. 98–175-02). For isolation of primary osteoblasts, calvariae from 7-day-old CD-1 neonatal mice (Charles River Laboratories, Inc., Boston, MA) were digested with collagenase and trypsin as previously described (48). Briefly, calvariae were digested in 0.5 mg/ml collagenase (Roche Molecular Biochemicals, Indianapolis, IN), 0.01% trypsin, and 0.1 mM EDTA for 10 min at a time, on a rocking platform at 37 C. Cells from five sequential passages were collected. Cells from the first passage were discarded while cells from passages 2–5 were pooled, plated at 15,000 cells/cm2 and grown in DMEM supplemented with 10% FBS, 100 U/ml penicillin and 50 µg/ml streptomycin in a humidified atmosphere of 5% CO2 at 37 C. Media was changed every 3 days. After 1 week, the cells were trypsinized, pooled, and stored in liquid nitrogen. For experiments, cells were removed from liquid nitrogen, plated at 10,000 cells/cm2, grown to confluence (7–10 days) in DMEM supplemented with 10% FBS, and treated appropriately.

Calvariae from 7-day-old CD-1 neonatal mice (Charles River Laboratories, Inc., Boston, MA) were excised and cut along the saggittal suture to give two hemicalvariae per animal. Calvariae were cultured in BGJb medium containing 1 mg/ml BSA, 100 µg/ml ascorbic acid, 100 U/ml penicillin, and 50 µg/ml streptomycin.

Representational difference analysis
Representational difference analysis (RDA) was performed as previously described (49). Briefly, poly A mRNA was extracted from Control (CHX-treated) and Tester (CHX and PTH-treated) cells using poly A RNA extraction columns (5'-3'), converted to double-stranded DNA (dsDNA) using a complementary DNA (cDNA) synthesis kit (Life Technologies, Inc., Grand Island, NY), and was digested with DpnII (New England Biolabs, Inc., Beverly, MA). Three sets of linkers were designed (49). The first set was ligated to the DpnII digests. Because the linkers were not phosphorylated, only the 3' end of the linker was ligated to the 5' strand of the dsDNAs. The unligated linker was melted away and the 3' strand of the dsDNAs was filled in by Taq polymerase at 72 C for 3 min. The DpnII digested, linker-modified dsDNA fragments were amplified by PCR using the ligated strand of the first set of linkers as a primer.

The linkers of the two representations (Control and Tester) were removed by digestion with DpnII, and a second set of linkers was ligated only to the Tester representation. Then the two representations were mixed at a Tester:Control ratio of 1:100. The mixture of dsDNAs was denatured at 95 C for 5 min and allowed to renature at 67 C for 16 h. The 3' strand of the second set of linkers was melted away and the 3' strand of the dsDNAs was filled in by Taq polymerase at 72 C for 3 min. The renatured/denatured mixture of dsDNAs was amplified by PCR using the 5' strand of the second set of linkers as a primer. After 10 PCR cycles the PCR products were digested with Mung Bean Nuclease (New England Biolabs, Inc., Beverly, MA). The complexes were PCR amplified for 18 additional cycles to form the first difference product, DP1. The DP1 dsDNAs were digested with DpnII to remove the second set of linkers and a third set of linkers was ligated as described above. The denaturation/renaturation step described above was repeated but with the DP1:Control ratio set at 1:10,000. The hybridization products were amplified as described but using the ligated strand of the third set of linkers as a PCR primer. The final PCR product constituted the second difference product, DP2 (Fig. 1BGo). The hybridization and selective amplification was repeated once again using a fourth set of linkers and a DP2:Control ratio of 1:1,000,000 to generate the final third difference product, DP3. DP3 PCR products were directly subcloned to the TA vector (Invitrogen, Carlsbad, CA) and sequenced with the dideoxy sequencing method using the Sequenase version 2.0 kit (Amersham Pharmacia Biotech, Arlington Heights, IL).



View larger version (62K):
[in this window]
[in a new window]
  		Figure 1. Representational difference analysis of mRNA from control (Cont, cycloheximide treated) and tester (PTH, cycloheximide + PTH-treated) cells. A, Initial representations were separated by 1% agarose gel electrophoresis. The representations appeared as a uniform streak of DNA molecules that ranged in size from 0.2–1.1 kb. Lane 1, M, Molecular weight marker. B, The first, second, and third Difference Products (DP1, DP2 and DP3, respectively) were separated by 5% PAGE. The representations ranged in size from 0.2–1.1 kb and contained several bands that became progressively more prominent. Lane 1, M, Molecular weight marker.

 
Northern blot analysis
Following the manufacturer’s protocol, total RNA was extracted using the TRIZOL reagent (Life Technologies, Inc., Grand Island, NY) and fractionated by electrophoresis on a 1% agarose gel containing 3.7% formaldehyde, then transferred to Gene Screen Plus hybridization membrane (NEN Life Science Products, Boston, MA). Filters were prehybridized for 20 min and hybridized for 1 h at 68 C using the QuikHyb hybridization solution (Stratagene, La Jolla, CA) in the presence of 2 x 107 counts of a [32]P labeled probe. Filters were washed and used to expose radiographic film (Fisher Scientific, Pittsburgh, PA). Nurr1 mRNA intensity was measured and corrected for GAPDH expression using phosphorimager screen (Molecular Dynamics, Inc., Sunnyvale, CA).

Extraction of total and nuclear proteins and Western blot analysis
Confluent MOB cells were collected in 10 ml ice-cold PBS and centrifuged at 2,000 x g for 5 min. For total protein extracts, cells were resuspended for 30 min in 1 ml triple detergent lysis buffer containing 50 mM Tris-Cl, 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 100 µg/ml PMSF 1 µg/ml aprotinin, 1% NP40 0.5% deoxycholate and 1x protease inhibitors. Lysates were spun at 15K for 15 min at 4 C, and supernatants were used for Western blot assays.

Nuclear protein extracts were prepared as previously described (50). Cells were resuspended in 400 µl buffer containing 10 mM HEPES buffer (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, and 1x protease inhibitors (Roche Molecular Biochemicals, Indianapolis, IN) for 15 min on ice. Twenty-five microliters of 10% NP-40 were added, and cells were vortexed vigorously for 10 sec. Cells were spun at maximum speed in microfuge for 30 sec at 4 C and pellets were resuspended in ice-cold buffer containing 20 mM HEPES buffer (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, and 1x protease inhibitors.

Fifty micrograms of total or 20 µg of nuclear proteins per sample were boiled for 5 min in 30 mM Tris-HCl (pH 6.8), 2.5% glycerol, 1% SDS, 350 mM 2-mercaptoethanol, and 0.0625% bromophenol blue (wt/vol). Samples were electrophoretically separated by a 10% polyacrylamide SDS-PAGE. Proteins were electrophoretically transferred to nitrocellulose membranes at 20 V for 16 h at 4 C. Membranes were stained with 0.1% Ponceau S (wt/vol) in 5% acetic acid (vol/vol) to determine equal loading. Immunoreactive species were determined using commercial rabbit polyclonal antibodies produced against the N- or C- terminus of rat Nurr1 proteins (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and antirabbit Ig, horseradish peroxidase linked whole antibody (Amersham Pharmacia Biotech) using the ECL western blotting detection reagent kit (Amersham Pharmacia Biotech).

Statistics
Data among groups were analyzed using one-way ANOVA and the Student-Newman-Keul’s post hoc test. Data between groups were analyzed using the Student’s t test.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
PTH induction of primary response genes
We performed the RDA technique to identify PTH-inducible primary response genes in osteoblastic cells. MC3T3-E1 cells were pretreated with the protein synthesis inhibitor cycloheximide (CHX, 10 µg/ml) for 30 min and then treated with vehicle (Driver) or PTH (10 nM) for 90 min (Tester). Cycloheximide treatment of osteoblasts at 3 µg/ml inhibits more than 93% of total protein synthesis (48). Poly A mRNA from each group was extracted and converted to double stranded DNA (dsDNA), which was then digested with DpnII and PCR amplified. The mixture of molecules generated ranged in size from 0.2–1.1 kb and contained the representation population for each group. Both representations of control and PTH-treated groups contained a uniform population of DNA molecules that looked similar when subjected to gel electrophoresis (Fig. 1AGo).

For RDA, representations of the two populations were mixed at a Tester:Driver ratio of 1:100 and PCR amplified to form the first difference product, DP1 (Fig. 1BGo), which was enriched for sequences preferentially found in the Tester. DP1 was mixed with Driver at 1:10,000 to generate the second difference product, DP2 (Fig. 1BGo). Finally, DP2 was mixed with Driver at 1:1,000,000 to generate the third difference product, DP3 (Fig. 1BGo). Gel electrophoresis of DP1, DP2, and DP3 revealed a mixture of molecules that ranged in size from 0.2–1.1 kb, comparable to the initial representations (Fig. 1AGo). However, several distinct bands of various sizes could be identified in the DP3 group in contrast to the uniform smear seen in the Control and Tester representations (compare Fig. 1Go, panel A with panel B, lane 4). These bands became progressively more prominent in DP2 and DP3 groups whereas most of the smear appearance of the DNA molecules was greatly reduced. Ninety-six DP3 products were subcloned and sequenced. Several inserts had the same sequence and represented the same gene segment. Unique sequences were compared with those in the GenBank database using the BLAST program to determine whether they matched known genes. Eight clones, representing 21% of the sequenced fragments, matched segments of three genes in the data bank: the enzyme prostagandin G/H synthase 2 (PGS2, cyclooxygenase 2), the transcription factor fos B, and the nuclear orphan receptor Nurr1.

To confirm that the DNA fragments identified by RDA were among genes induced by PTH treatment of osteoblasts in the absence of protein synthesis, we treated confluent MC3T3-E1 cells with CHX (10 µg/µl) for 30 min followed by PTH (10 nM) for 90 min. Total RNA was extracted and subjected to Northern blot analysis using the RDA-isolated gene fragments as cDNA probes. Control cells showed very low levels of PGS2, fos B and Nurr1 mRNA, whereas PTH strongly induced their expression (Fig. 2Go).



View larger version (34K):
[in this window]
[in a new window]
  		Figure 2. PTH induces prostaglandin G/H synthase-2 (cyclooxygenase-2, PGS-2), fos B and Nurr1 mRNA levels in the presence of cycloheximide. MC3T3-E1 cells were pretreated for 1 h with 10 µg/ml cycloheximide, then with vehicle (C) or 10 nM PTH for 90 min. Total RNA was extracted and mRNA levels of various genes were determined by Northern blot analysis. The last inset shows ethidium bromide (eth br) staining of 28S and 18S rRNA.

 
PTH induces Nurr1 in primary osteoblasts derived from neonatal mouse calvariae
MC3T3-E1 cells are spontaneously immortalized preosteoblastic cells. To ensure that PTH induction of Nurr1 is not unique to MC3T3-E1 cells and is, in fact, a normal osteoblastic response, we assayed cells derived from neonatal (7–8 days old) mouse calvariae (MOB cells) for Nurr1 expression following PTH treatment. Each experiment was performed at least three times with similar results.

PTH rapidly and transiently induced Nurr1 mRNA levels that peaked at 1–2 h (30-fold greater than untreated control), returned to almost control levels within 4 h of treatment (Fig. 3Go, A and B), and remained at basal levels up to 24 h after PTH treatment. Nurr1 transcript was approximately 3.5 kb in agreement with previously published data (29). PTH induction was detectable at 10 pM, and maximal at 10 and 1 nM PTH (Fig. 4Go, A and B). Half-maximal dose was approximately 0.1 nM PTH.



View larger version (32K):
[in this window]
[in a new window]
  		Figure 3. PTH rapidly and transiently induces Nurr1 mRNA levels in primary osteoblasts. A, Time course of the effect of PTH. MOB cells were grown to confluence and treated for various times with 10 nM PTH(1–34). Nurr1 and GAPDH mRNA levels were determined by Northern blot analysis. Ethidium bromide staining of RNA is shown. B, Densitometric values for Nurr1 mRNA levels were expressed as percent maximal induction for time course experiments. Each value is the mean ± SEM of six different experiments. **, P < 0.001, *, P < 0.05.

 


View larger version (28K):
[in this window]
[in a new window]
  		Figure 4. Dose response effect of PTH. A, MOB cells were grown to confluence and treated for 1 h with various concentrations of PTH. Nurr1 and GAPDH mRNA levels were determined by Northern blot analysis. Ethidium bromide staining of RNA is shown. B, Densitometric values for Nurr1 mRNA levels were expressed as percent maximal induction for dose-response experiments. Each value is the mean ± SEM of three different experiments.

 
PTH induces Nurr1 mRNA levels mainly through the cAMP-PKA pathway
PTH binds to the plasma membrane PTHR1 receptor and activates the cAMP-PKA, PKC, and calcium pathways (12). To examine which of these pathways can induces Nurr1 mRNA levels, MOB cells were treated with: forskolin (FSK, 10 µM), which activates adenylate cyclase; phorbol ester (PMA, 1 µM), which activates protein kinase C; or ionomycin (iono, 1 µM), a calcium ionophore that increases calcium influx and thereby raises the intracellular calcium concentration. Both FSK and PMA, but not ionomycin, increased Nurr1 mRNA levels above baseline at 1 h (Fig. 5Go). However, FSK induction was higher than PMA and similar to PTH induction of Nurr1 mRNA levels.



View larger version (65K):
[in this window]
[in a new window]
  		Figure 5. Effect of agents that activate PKA and PKC signaling and increase intracellular calcium on Nurr1 mRNA levels. MOB cells were treated with 10 nM PTH(1–34), 10 µM FSK, 1 µM PMA or 1 µM ionomycin (iono) for 1 h. Northern blot analysis of Nurr1 and GAPDH mRNA levels and ethidium bromide staining of RNA are shown. C, Control cells.

 
To determine the role of the PKA signaling pathway, cells were pretreated for 1 h with the PKA inhibitor H89 at 10 or 30 µM and then treated with PTH (10 nM) or FSK (10 µM) for 1 h. H89 at 30 µM significantly inhibited PTH and FSK induction of Nurr1 mRNA levels by 75% and 83%, respectively. H89 at 10 nM showed a smaller inhibition of the PTH and FSK effect (Fig. 6Go, A and B).



View larger version (43K):
[in this window]
[in a new window]
  		Figure 6. Effect of PKA inhibition on PTH induction of Nurr1 mRNA levels. A, MOB cells were pretreated with vehicle, 10 µM or 30 µM H89 for 1 h and then treated with 10 nM PTH, or 10 µM FSK for 1 h. Nurr1 and GAPDH mRNA levels were determined by Northern blot analysis. Ethidium bromide staining of RNA is shown. B, Densitometric values for Nurr1 mRNA levels were expressed as percent PTH-maximal induction. Each value is the mean ± SEM of three different experiments. *, Significantly different from the 0 µM H89-treated group, P < 0.01.

 
To assess the involvement of the PKC pathway, MOB cells were pretreated with PMA (1 µM) for 16 h, and then treated with PTH or PMA for 1 h. Prolonged treatment with phorbol esters down-regulates PKC activity (51, 52). Pretreatment with PMA blocked the ability of freshly added PMA to induce Nurr1 mRNA levels but did not affect the PTH induction (Fig. 7Go, A and B).



View larger version (37K):
[in this window]
[in a new window]
  		Figure 7. Effect of PKC inhibition on PTH induction of Nurr1 mRNA levels. A, MOB cells were pretreated with vehicle or 1 µM PMA for 16 h and then treated with 10 nM PTH, or 1 µM PMA for 1 h. Nurr1 and GAPDH mRNA levels were determined by Northern blot analysis. Ethidium bromide staining of RNA is shown. B, Densitometric values for Nurr1 mRNA levels were expressed as percent maximal induction. Each value is the mean ± SEM of three different experiments. *, Significantly different from the vehicle (-PMA) treated group, P < 0.001.

 
To further examine the role of the cAMP-PKA pathway in the PTH induction of Nurr1 gene expression, cells were treated with the PTH analog PTH (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34). Deletion of the two N-terminal amino acids abolishes the ability of PTH to activate the cAMP-PKA pathway (53). As much as 100 nM PTH (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34) did not induce Nurr1 mRNA levels, in contrast to 10 nM PTH (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34) (Fig. 8Go).

PTH induces Nurr1 mRNA levels in mouse calvariae cultures
To determine whether PTH induced Nurr1 mRNA expression in bone tissue, neonatal mouse calvariae were treated with PTH (10 nM) for 0–8 h in serum-free media. Total RNA was extracted and was subjected to Northern blot analysis. Nurr1 mRNA levels were almost undetectable in the control group. PTH treatment resulted in rapid induction of Nurr1 mRNA levels that peaked at 1 h and declined thereafter (Fig. 9Go).



View larger version (59K):
[in this window]
[in a new window]
  		Figure 9. PTH induces Nurr1 mRNA levels in mouse calvariae organ cultures. Neonatal mouse calvariae were dissected and cultured in serum-free BGJb medium. Calvariae were treated for various times with 10 nM PTH. Nurr1 and GAPDH mRNA levels were determined by Northern blot analysis. Ethidium bromide staining of RNA is shown.

 
PTH induces Nurr1 protein in MOB cells
To establish that PTH induction of Nurr1 mRNA results in induction of Nurr1 protein, MOB cells were treated with PTH for 0–6 h and nuclear proteins were extracted. Proteins were separated by 10% SDS-PAGE and subjected to Western blot analysis using a commercial Nurr1 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Nuclear and total protein extracts from cells treated with PTH for 2 h contained a Nurr1-immunoreactive doublet band around 66 kDa, which was absent in control cells and at low levels 4 h after treatment. Figure 10Go shows a representative experiment using nuclear protein extracts. The predicted and previously published size for Nurr1 protein is 66 kDa (29, 31).



View larger version (15K):
[in this window]
[in a new window]
  		Figure 10. PTH induces Nurr1 protein expression in MOB cells. MOB cells were treated for 0–6 h with PTH (10 nM). Nuclear proteins were extracted and the level of Nurr1 immunoreactive proteins was measured by Western blot analysis. The migration of molecular weight markers (M) is indicated on the left.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
PTH is a major regulator of osteoblast function and has important effects on bone metabolism. Intermittent low-dose PTH stimulates bone formation, whereas continuous PTH decreases osteoblastic activity and increases bone resorption (54). It appears that initial events after PTH treatment are sufficient to induce an anabolic response, whereas late events lead to catabolic activity. Therefore, understanding early changes in osteoblast gene expression is important in deciphering the molecular signals that mediate the PTH effects on bone metabolism.

Identification of primary response genes induced by PTH in osteoblastic cells has been the subject of previous studies. A fragment of a novel PTH-responsive gene was isolated after treatment of SaoS-2/B10 osteoblastic cells with PTH for 1 h (55), and RGS-2 (the regulator of G protein signaling-2) was isolated from femurs of rats treated in vivo with PTH for 1 h (21). Both techniques used the differential display screening method (56). In our study, we pretreated MC3T3-E1 cells with cycloheximide to ensure that protein synthesis was not required for the induction of the identified genes. Also, we used RDA because of its high sensitivity, the kinetic enrichment achieved by the subtractive process, and low false positive ratio (49). Using this approach, we discovered that the nuclear orphan receptor Nurr1 is strongly induced by PTH in the absence of new protein synthesis. To our knowledge, PTH regulation of Nurr1 gene expression has not been reported previously.

PTH induction of Nurr1 gene expression was maximal at 1 h and at 10 nM of hormone. Although activation of both PKA and PKC pathways induced Nurr1 mRNA levels, the PTH effect appears to be mediated mainly through cAMP-PKA signaling as suggested by three lines of evidence. First, inhibition of PKA attenuated the ability of PTH and FSK to induce Nurr1 mRNA levels to a similar extent. Second, inhibition of PKC signaling, which blocked the PMA effect, did not affect PTH induction of Nurr1 gene expression. Finally, the PTH analog PTH (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34) that does not activate the cAMP-PKA pathway (53), did not induce Nurr1 mRNA levels.

cAMP-PKA regulation of transcription is mediated by activation and binding of CREB/ATF transcription factors at cAMP response element (CRE) on the promoters of various genes (57). Isolation and sequencing of the 900 bp of the Nurr1 promoter revealed a consensus CRE, as well as glucocorticoid response element (GRE), SP1, and AP-1 binding sites (58, 59). Because our data indicate the cAMP-PKA pathway plays a major role in the PTH regulation of Nurr1 gene expression the CRE becomes a major candidate cis element to mediate potential regulation of the Nurr1 promoter by PTH. On the other hand, the AP-1 binding site has been implicated in the PTH induction of collagenase promoter activity (60, 61) suggesting a possible role for this site in PTH regulation of Nurr1 gene expression.

Nurr1 cDNA encodes a protein of 598 amino acids with a calculated molecular weight of 66 kDa (29). A Nurr1-immunoreactive doublet was observed in peripheral blood T cells treated with the combination of the calcium ionophore A23187 and PMA. The appearance of a doublet was attributed to the utilization of alternative translation initiation site (31). In our studies, PTH also induced a Nurr1 immunoreactive doublet with a molecular weight of approximately 66 kDa in MOB cells.

Nurr1 belongs to the family of nuclear receptors and activates transcription in the absence of ligand binding. Nurr1 binds DNA as a monomer and enhances 40-fold the activity of a reporter construct containing a NUR consensus binding-site upstream of the minimal globin promoter (30). Nurr1 binds to a GAAGGTCA cis-acting sequence and activates the promoter of the POMC gene. Nurr1 binding is specific and mutation of this element abolishes Nurr1’s ability to induce POMC promoter activity. Furthermore, this element confers Nurr1 regulation when placed upstream of a heterologous promoter (62).

We identified Nurr1 protein both in total and nuclear protein extracts of MOB cells. This suggests that newly synthesized Nurr1 is targeted in the nucleus, presumably where it will bind to promoter elements and regulate the transcription of late response osteoblastic genes. We performed computer analysis to identify potential Nurr1 binding sites in promoter and enhancer sequences of genes important for osteoblastic function (data not shown). Several sites that contained seven of the eight nucleotides of the consensus Nurr1 binding site were revealed. Genes with Nurr1 binding sites in their promoter/enhancer area included alkaline phosphatase, bone sialoprotein, osteocalcin, type I (a)1 and type I (a)2 collagen, insulin growth factor I, and collagenase.

Nurr1 is also involved in 9-cis retinoic acid receptor (RXR) signaling. RXR heterodimerization with the retinoic acid receptor (RAR) or the thyroid hormone receptor (T3R) abolishes RXR’s ability to bind ligand and activate transcription. However, RXR is able to heterodimerize with Nurr1 and activate transcription (32, 33). RXR-Nurr1 heterodimers bind specifically to direct DNA repeats spaced by five nucleotides. Dimerization with RXR appears to involve the carboxy-terminal domain of Nurr1 (33, 63). RXR can also heterodimerize with the vitamin D receptor to bind DNA (34). Regulation of RXR availability and activity by Nurr1 can modify vitamin D, retinoic acid, and thyroid hormone signaling (33). PTH and vitamin D, the two major calciotropic hormones, have synergistic effects on bone resorption (64) and induction of osteoblastic genes, such as vitamin D receptor, 24 hydroxylase and osteocalcin (65, 66). Therefore, induction of Nurr1 gene expression in bone suggests a potential cross-talk mechanism between PTH and vitamin D, or other steroid hormone signaling in regulating bone metabolism.


   Acknowledgments
 
We would like to thank Drs. Barbara Kream, Jeanne Nervina, and Sharon Hunt Gerardo for helpful and insightful suggestions during the preparation of the manuscript.


   Footnotes
 
1 This work was supported by NIH Grant R-01-DE-13316. Back

Received May 23, 2000.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Jerome CP, Gubler HP 1991 Experimental determination of "the law of bone remodeling" and effect of rat parathyroid hormone (1–34) infusion on derived parameters. Calcif Tissue Int 49:398–402[Medline]
  2. Jerome CP, Colwell A, Eastell R, Russell RG, Trechsel U 1992 The effect of rat parathyroid hormone (1–34) infusion on urinary 3-hydroxypyridinium cross-link excretion in the rat. Bone Miner 19:117–125[CrossRef][Medline]
  3. Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevensosn RW, Zanelli JM 1983 Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112:1000–1006[Abstract]
  4. Nishida S, Yamaguchi A, Tanizawa T, Endo N, Mashiba T, Uchiyama Y, Suda T, Yoshiki S, Takahashi HE 1994 Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 15:717–723[Medline]
  5. Juppner H, Abou-Samra A, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski Jr LF, Hock J, Potts Jr JT, Kronenberg HM, Segre GV 1991 A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024–1025[Abstract/Free Full Text]
  6. Abou-Samra AB, Jupner H, Force T, Freeman MW, Kong XF, Schipani A, Urena P, Richards J, Bonvetre JV, Potts Jr JT, Kronenberg HM, Segre GV 1992 Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA 89:2732–2736[Abstract/Free Full Text]
  7. Abou-Samra AB, Jueppner H, Westerberg D, Potts Jr JT 1989 Parathyroid hormone causes translocation of protein kinase-C from cytosol in membranes in rat osteosarcoma cells. Endocrinology 124:1107–1113[Abstract]
  8. Teitelbaum AP, Nissenson RA, Zitzner LA, Simon K 1986 Dual regulation of PTH-stimulated adenylate cyclase activity by GTP. Am J Physiol 251:F858–F864
  9. Fukayama S, Tashjian AJ, Bringhurst FR 1992 Mechanisms of desensitization to parathyroid hormone in human osteoblast-like SaOS-2 cells. Endocrinology 131:1757–1769[Abstract]
  10. Pines M, Santora A, Gierschik P, Menczel J, Spiegel A 1986 The inhibitory guanine nucleotide regulatory protein modulates agonist-stimulated cAMP production in rat osteosarcoma cells. Bone Miner 1:15–26[Medline]
  11. Dunlay R, Hruska K 1990 PTH receptor coupling to phospholipase C is an alternate pathway of signal transduction in bone and kidney. Am J Physiol 258:F223–F231
  12. Fujimori A, Cheng S, Avioli LV, Civitelli R 1992 Structure-function relationship of parathyroid hormone: activation of phopholipase-C, protein kinase-A and -C in osteosarcoma cells. Endocrinology 130:29–36[Abstract]
  13. Abou-Samra AB, Jueppner H, Potts Jr JT, Segre GV 1989 Inactivation of pertussis toxin-sensitive guanyl nucleotide-binding proteins increase parathyroid hormone receptors and reverse agonist-induced receptor down- regulation in ROS 17/2.8 cells. Endocrinology 125:2594–2599[Abstract]
  14. Hucho F, Buchner K 1997 Signal transduction and protein kinases: the long way from the plasma membrane into the nucleus. Naturwissenschaften 84:281–290[CrossRef][Medline]
  15. Clohisy JD, Scott DK, Brakenhoff KD, Partridge NC 1991 Parathyroid hormone stimulation of c-Fos and c-Jun mRNA in osteoblastic cells: an immediate early response. J Bone Miner Res [Suppl] 6:S134
  16. Clohisy JC, Scott DK, Brakenhoff KD, Quinn CO, Partridge NC 1992 Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells. Mol Endocrinol 6:1834–1842[Abstract]
  17. Pearman AT, Chou W-Y, Bergman KD, Pulumati MR, Partridge NC 1996 Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE. J Biol Chem 271:25715–25721[Abstract/Free Full Text]
  18. Tetradis S, Nervina JM, Nemoto K, Kream BE 1998 Parathyroid hormone induces expression of the inducible cAMP early repressor in osteoblastic MC3T3–E1 cells and mouse calvariae. J Bone Miner Res 13:1846–1851[CrossRef][Medline]
  19. Greenfield EM, Shaw SM, Gornik SA, Banks MA 1995 Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest 96:1238–1244
  20. Greenfield EM, Horowitz MC, Lavish SA 1996 Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction. J Biol Chem 271:10984–10989[Abstract/Free Full Text]
  21. Miles RR, Sluka JP, Santerre RF, Hale LV, Bloem L, Boguslawski G, Thirunavukkarasu K, Hock JM, Onyia JE 2000 Dynamic regulation of RGS2 in bone: potential new insights into parathyroid hormone signaling mechanisms. Endocrinology 141:28–36[Abstract/Free Full Text]
  22. Tetradis S, Pilbeam C, Liu Y, Kream B 1996 Parathyroid hormone induces prostaglandin G/H synthase-2 expression by a cyclic adenosine 3',5'-monophosphate-mediated pathway in the murine osteoblastic cell line MC3T3–E1. Endocrinology 137:5435–5440[Abstract]
  23. Tetradis S, Pilbeam CC, Liu Y, Herschman HR, Kream BE 1997 Parathyroid hormone increases prostaglanding G/H synthase-2 transcription by a cyclic adenosine 3',5'-monophosphate-mediated pathway in murine osteoblastic MC3T3–E1 cells. Endocrinology 138:3594–3600[Abstract/Free Full Text]
  24. Catherwood BD, Titus L, Evans C, Rubin J, Boden SD, Naves MS 1994 Increased expression of tissue plasminogen activator messenger ribonucleic acid is an immediate response to parathyroid hormone in neonatal rat osteoblasts. Endocrinology 134:1429–1436[Abstract]
  25. Kream BE, LaFrancis D, Petersen DN, Woody C, Clark S, Rowe DW, Lichtler A 1993 Parathyroid hormone represses a1(I) collagen promoter activity in cultured calvariae from neonatal transgenic mice. Mol Endocrinol 7:399–408[Abstract]
  26. Scott DK, Brakenhoff KD, Clohisy JC, Quinn CO, Partridge NC 1992 Parathyroid hormone induces transcription of collagenase in rat osteoblastic cells by a mechanism using cyclic adenosine 3',5'-monophosphate and requiring protein synthesis. Mol Endocrinol 6:2153–2159[Abstract]
  27. Chou WY, Pulumati MR, Pearman AT, Bergman KD, Partridge NC 1995 Mapping of the parathyroid hormone regulatory elements in the rat collagenase gene. J Bone Miner Res [Suppl 1] 10:S213
  28. Onyia JE, Bidwell J, Herring J, Hulman J, Hock JM 1995 In vivo, human parathyroid hormone fragment (hPTH 1–34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone 17:479–484[Medline]
  29. Law SW, Conneely OM, DeMayo FJ, O’Malley BW 1992 Identification of a new brain-specific transcription factor, NURR1. Mol Endocrinol 6:2129–2135[Abstract]
  30. Scearce LM, Laz TM, Hazel TG, Lau LF, Taub R 1993 RNR-1, a nuclear receptor in the NGFI-B/Nur77 family that is rapidly induced in regenerating liver. J Biol Chem 268:8855–8861[Abstract/Free Full Text]
  31. Mages HW, Rilke O, Bravo R, Senger G, Kroczek RA 1994 NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3. Mol Endocrinol 8:1583–1591[Abstract]
  32. Forman BM, Umesono K, Chen J, Evans RM 1995 Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541–550[CrossRef][Medline]
  33. Perlmann T, Jansson L 1995 A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 9:769–782[Abstract/Free Full Text]
  34. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Näär AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG 1991 RXRbeta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251–1266[CrossRef][Medline]
  35. Xing G, Zhang L, Zhang L, Heynen T, Li XL, Smith MA, Weiss SR, Feldman AN, Detera-Wadleigh S, Chuang DM, Post RM 1997 Rat Nurr1 is prominently expressed in perrhinal cortex, and differentially induced in the hippocampal dentate gyrus by electroconvulsive vs. kindled seizures. Brain Res Mol Brain Res 47:251–161[Medline]
  36. Saucedo-Cardenas O, Conneely OM 1996 Comparative distribution of NURR1 and NUR77 nuclear receptors in the mouse central nervous system. J Mol Neurosci 7:51–63[Medline]
  37. Xiao Q, Castillo SO, Nikodem VM 1996 Distribution of messenger RNAs for the orphan nuclear receptors Nurr1 and Nur77 (NGFI-B) in adult rat brain using in situ hybridization. Neuroscience 75:221–230[CrossRef][Medline]
  38. Zetterstrom RH, Williams R, Perlmann T, Olson L 1996 Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res Mol Brain Res 41:111–120[Medline]
  39. Honkaniemi J, Sagar SM, Pyykonen I, Hicks KJ, Sharp FR 1995 Focal brain injury induces multiple immediate early genes encoding zinc finger transcription factors. Brain Res Mol Brain Res 28:157–163[Medline]
  40. Honkaniemi J, Sharp FR 1996 Global ischemia induces immediate-early genes encoding zinc finger transctiption factors. J Cereb Blood Flow Metab 16:557–565[CrossRef][Medline]
  41. Nakki R, Sharp FR, Sagar SM, Hondaniemi J 1996 Efffects of phencyclidine on immediate early gene expression in the brain. J Neurosci Res 45:13–27[CrossRef][Medline]
  42. Honkaniemi J, States BA, Weinstein PR, Espinoza J, Sharp FR 1997 Expression of zinc finger immediate early genes in rat brain after permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab 17:636–646[CrossRef][Medline]
  43. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T 1997 Dopamine neurons agenesis in Nurr1-deficient mice. Science 276:248–250[Abstract/Free Full Text]
  44. Maruyama K, Tsukada T, Bandoh S, Sasaki K, Ohkura N, Yamaguchi K 1995 Expression of NOR-1 and its closely related members of the steroid/thyroid hormone receptor superfamily in human neuroblastoma cell lines. Cancer Lett 96:117–122[CrossRef][Medline]
  45. Davis IJ, Lau LF 1994 Endocrine and neurogenic regulation of the orphan nuclear receptors Nur77 and Nurr-1 in the adrenal glands. Mol Cell Biol 14:3469–3483[Abstract/Free Full Text]
  46. Bandoh S, Tsukada T, Maruyama I, Ohkura N, Yamaguchi K 1997 Mechanical agitation induces gene expression of NOR-1 and its closely related orphan nuclear receptors in leukemic cell lines. Leukemia 11:1453–1458[CrossRef][Medline]
  47. Maruyama K, Tsukada T, Bandoh S, Sasaki K, Ohkura N, Yamaguchi K 1997 Retinoic acids differentially regulate NOR-1 and its closely related orphan nuclear receptor genes in breast cancer cell line MCF-7. Biochem Biophys Res Commun 231:417–420[CrossRef][Medline]
  48. Krebsbach PH, Harrison JH, Lichtler AC, Woody CO, Rowe DW, Kream BE 1993 Transgenic expression of COL1A1-CAT fusion genes in bone: differential utilization of promoter elements in vivo and in cultured cells. Mol Cell Biol 13:5168–5174[Abstract/Free Full Text]
  49. Hubank M, Schatz DG 1994 Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22:5640–5648[Abstract/Free Full Text]
  50. Tomaras GD, Foster DA, Burrer CM, Taffet SM 1999 ETS transcription factors regulate an enhancer activity in the third intron of TNF-{alpha}. J Leukoc Biol 66:183–193[Abstract]
  51. Blackshear PJ, Witters LA, Girard PA, Kuo JF, Quamo SN 1985 Growth factor-stimulated protein phosphorylation in 3T3–L1 cells. Evidence for protein kinase C-dependent and independent pathways. J Biol Chem 260:13304–13315[Abstract/Free Full Text]
  52. Sanders JL, Stern PH 2000 Protein kinase C involvement in interleukin-6 production by parathyroid hormone and tumor necrosis factor-{alpha} in UMR-106 osteoblastic cells. J Bone Miner Res 15:885–893[CrossRef][Medline]
  53. Fujimori A, Cheng S, Avioli LV, Civitelli R 1991 Dissociation of second messenger activation by parathyroid hormone fragments in osteosarcoma cells. Endocrinology 128: 3032–3039
  54. Finkelstein JS 1996 Pharmacological mechanisms of therapeutics: parathyroid hormone. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of Bone Biology. Academic Press, San Diego, CA, pp 993–1005
  55. Adams AE, Rosenblatt M, Suva LJ 1999 Identification of a novel parathyroid hormone-responsive gene in human osteoblastic cells. Bone 24:305–313[Medline]
  56. Liang P, Pardee AB 1992 Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction [see comments]. Science 257:967–971[Abstract/Free Full Text]
  57. Meyer TE, Habener JF 1993 Cyclic adenosine 3',5'-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr Rev 14:269–290[CrossRef][Medline]
  58. Castillo SO, Xiao Q, Lyu MS, Kozak CA, Nikodem VM 1997 Organization, sequence, chromosomal localization, and promoter identification of the mouse orphan nuclear receptor Nurr1 gene. Genomics 41:250–257[CrossRef][Medline]
  59. Saucedo-Cardenas O, Kardon R, Ediger TR, Lydon JP, Conneely OM 1997 Cloning and structural organization of the gene encoding the murine nuclear receptor transcription factor, NURR1. Gene 187:135–139[CrossRef][Medline]
  60. Rajakumar RA, Quinn CO 1996 Parathyroid hormone induction of rat interstitial collagenase mRNA in osteosarcoma cells is mediated through an AP-1-binding site. Mol Endocrinol 10:867–878[Abstract]
  61. Selvamurugan N, Chou WY, Pearman AT, Pulumati MR, Partridge NC 1998 Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J Biol Chem 273:10647–10657[Abstract/Free Full Text]
  62. Murphy EP, Conneely OM 1997 Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinol 11:39–47[Abstract/Free Full Text]
  63. Zetterstrom RH, Solomin L, Mitsiadis T, Olson L, Perlmann T 1996 Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1 and Nor1. Mol Endocrinol 10:1656–1666[Abstract]
  64. van Leeuwen JP, Birkenhager JC, Bos MP, van der Bemd GJ, Herrmann-Erlee MPM, Pols HA 1992 Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25-dihydroxyvitamin D3. J Bone Miner Res 7:303–309[Medline]
  65. van Leeuwen JP, Birkenhager JC, van den Bemd GC, Pols HA 1996 Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone. Biochim Biophys Acta 1312:54–62[Medline]
  66. Krishnan AV, Cramer SD, Bringhurst FR, Feldman D 1995 Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenge pathways. Endocrinology 136:705–712[Abstract]



This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
L. C. Chao, Z. Zhang, L. Pei, T. Saito, P. Tontonoz, and P. F. Pilch
Nur77 Coordinately Regulates Expression of Genes Linked to Glucose Metabolism in Skeletal Muscle
Mol. Endocrinol., September 1, 2007; 21(9): 2152 - 2163.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. S. Mix, M. G. Attur, H. Al-Mussawir, S. B. Abramson, C. E. Brinckerhoff, and E. P. Murphy
Transcriptional Repression of Matrix Metalloproteinase Gene Expression by the Orphan Nuclear Receptor NURR1 in Cartilage
J. Biol. Chem., March 30, 2007; 282(13): 9492 - 9504.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Calebiro, T. de Filippis, S. Lucchi, F. Martinez, P. Porazzi, R. Trivellato, M. Locati, P. Beck-Peccoz, and L. Persani
Selective Modulation of Protein Kinase A I and II Reveals Distinct Roles in Thyroid Cell Gene Expression and Growth
Mol. Endocrinol., December 1, 2006; 20(12): 3196 - 3211.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. R. Holla, J. R. Mann, Q. Shi, and R. N. DuBois
Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer
J. Biol. Chem., February 3, 2006; 281(5): 2676 - 2682.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Q. Pirih, A. Tang, I. C. Ozkurt, J. M. Nervina, and S. Tetradis
Nuclear Orphan Receptor Nurr1 Directly Transactivates the Osteocalcin Gene in Osteoblasts
J. Biol. Chem., December 17, 2004; 279(51): 53167 - 53174.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. C. Ozkurt, F. Q. Pirih, and S. Tetradis
Parathyroid Hormone Induces E4bp4 Messenger Ribonucleic Acid Expression Primarily through Cyclic Adenosine 3',5'-Monophosphate Signaling in Osteoblasts
Endocrinology, August 1, 2004; 145(8): 3696 - 3703.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. A. K. Harvey, S. C. Anderson, and N. SundarRaj
Downstream Effects of ROCK Signaling in Cultured Human Corneal Stromal Cells: Microarray Analysis of Gene Expression
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2168 - 2176.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. Lammi, J. Huppunen, and P. Aarnisalo
Regulation of the Osteopontin Gene by the Orphan Nuclear Receptor NURR1 in Osteoblasts
Mol. Endocrinol., June 1, 2004; 18(6): 1546 - 1557.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
D. Liu, H. Jia, D. I. R. Holmes, A. Stannard, and I. Zachary
Vascular Endothelial Growth Factor-Regulated Gene Expression in Endothelial Cells: KDR-Mediated Induction of Egr3 and the Related Nuclear Receptors Nur77, Nurr1, and Nor1
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2002 - 2007.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. M. Fass, J. E. F. Butler, and R. H. Goodman
Deacetylase Activity Is Required for cAMP Activation of a Subset of CREB Target Genes
J. Biol. Chem., October 31, 2003; 278(44): 43014 - 43019.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. C. Ozkurt and S. Tetradis
Parathyroid Hormone-induced E4BP4/NFIL3 Down-regulates Transcription in Osteoblasts
J. Biol. Chem., July 11, 2003; 278(29): 26803 - 26809.
[Abstract] [Full Text] [PDF]

Home page